FDA Approves First New Non-Opiod Painkiller in Decades
Journavx is designed to eliminate the risks of addiction and overdose associated with medications like Vicodin and OxyContin.
Too Old to Operate57m
FDA Approved Dermatologic Therapies in 2024
The following is a summary of “A year in review: new treatments and expanded indications in dermatology in 2024,” published in the January 2025 issue of Dermatology by McGrath et al. In 2024, ...
New type of non-opioid pain medication approved by FDA
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
Hosted on MSN6m
FDA Approves Non-Opioid Painkiller to Combat Addiction Crisis
The US Food and Drug Administration (FDA) has approved Journavx, a new non-opioid painkiller for short-term pain in adults.
Sun Pharma Q3FY25 results: Net profit soars 15% to Rs 2,903.3 crore
Sequentially, revenue from operations grew by 2.9 per cent, whereas profit after tax (PAT) fell by 4.5 per cent ...
Patients who allegedly got fake Botox or Botox from unlicensed injectors speak out
Joey Luther was arrested last week and charged with wire fraud, smuggling and distributing counterfeit drugs for allegedly selling fake Botox.